Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Sales, net	$ 46,954	$ 42,214
Cost of sales	40,287	36,710
Gross profit	6,667	5,504
Selling and administrative expenses	3,480	3,390
Operating income	3,187	2,114
Other income (expense), net:
Interest expense	(911)	(953)
Change in fair value of derivative liability	(427)	(64)
Impairment on investment in iBio Stock	(36)
Other income, net	43	92
Total other expense, net	(1,331)	(925)
Income before income taxes	1,856	1,189
Income tax (benefit) expense, net	(490)	231
Net income	2,346	958
Expenses related to Convertible Debt - CD Financial, LLC:
Change in fair value of derivative liability	427
Interest expense, net of taxes	195
Amortization of prepaid financing costs, net of taxes	6
Accretion of convertible debt	39
Diluted net income	$ 3,013	$ 958
Basic net income per common share (in dollars per share)	$ 0.11	$ 0.05
Diluted net income per common share (in dollars per share)	$ 0.10	$ 0.05
Weighted average common shares outstanding - basic (in shares)	21,117,078	21,105,174
Add: Equivalent shares outstanding - stock options (in shares)	825,893	85,892
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)	8,230,769
Weighted average common shares outstanding - diluted (in shares)	30,173,740	21,191,066